{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:47:11Z","timestamp":1785930431815,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bulcan.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:22:08Z","timestamp":1785928928000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vie sexuelle et reproductive des hommes et femmes atteints de leuc\u00e9mie my\u00e9lo\u00efde chronique\u00a0: opinion et propositions pratiques du groupe Fi-LMC"],"prefix":"10.1016","author":[{"given":"Fran\u00e7oise","family":"Huguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanti","family":"Ame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Balsat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9leste","family":"Becquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cony-Makhoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Damase-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Dubruille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Escoffre-Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Legros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Penot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Roth-Guepin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Simonet-Boissard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2026.04.002_bib0160","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720966120","article-title":"Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations","volume":"11","author":"Abruzzese","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clml.2023.11.011","article-title":"SOHO state of the art updates and next questions: chronic myeloid leukemia and pregnancy: \u201cPer Aspera Ad Astra\u201d","volume":"24","author":"Abruzzese","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"Suppl. 1","key":"10.1016\/j.bulcan.2026.04.002_bib0170","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1182\/blood-2023-188305","article-title":"On the children side. overview of 194\u00a0outcomes from gimema registry of conception\/pregnancy in chronic myeloid leukemia (CML)","volume":"42","author":"Abruzzese","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.HS9.0000561804.14876.ab","article-title":"Pregnancy outcome in female patients with chronic myeloid leukemia worldwide: analysis of 305\u00a0cases of the European leukemia net registry: s881","volume":"3","author":"Chelysheva","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0180","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41375-025-02664-w","article-title":"2025\u00a0European LeukemiaNet recommendations for the management of chronic myeloid leukemia","volume":"39","author":"Apperley","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.6004\/jnccn.2024.0007","article-title":"Chronic myeloid leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Shah","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0190","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/jcm11071801","article-title":"Chronic myeloid leukemia and pregnancy: when dreams meet reality. state of the art, management and outcome of 41\u00a0cases, nilotinib placental transfer","volume":"11","author":"Abruzzese","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0195","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/ajh.24186","article-title":"The impact of dasatinib on pregnancy outcomes","volume":"90","author":"Cortes","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0200","doi-asserted-by":"crossref","first-page":"IJH26","DOI":"10.2217\/ijh-2020-0004","article-title":"Pregnancy outcomes in patients treated with bosutinib","volume":"9","author":"Cortes","year":"2020","journal-title":"Int J Hematol Oncol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0205","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2024-200186","article-title":"The impact of ponatinib on pregnancy outcomes","volume":"144","author":"Abruzzese","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0210","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00277-025-06238-9","article-title":"Twin pregnancy during treatment with asciminib for chronic myeloid leukemia\u2013a case report","volume":"104","author":"Gutierrez de Moraes Pereira","year":"2025","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0215","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.repbio.2021.100527","article-title":"Imatinib reduces the fertility of male mice by penetrating the blood-testis barrier and inducing spermatogonia apoptosis","volume":"3","author":"Chang","year":"2021","journal-title":"Reprod Biol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.leukres.2016.07.008","article-title":"CML patients show sperm alterations at diagnosis that are not improved with imatinib treatment","volume":"48","author":"Nicolini","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00404-016-4262-z","article-title":"Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers","volume":"295","author":"Carlier","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0230","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/cancers16040791","article-title":"Male fertility and fatherhood in chronic myeloid leukemia: current understanding and future perspectives","volume":"16","author":"Elsabagh","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/shem.2003.50038","article-title":"Imatinib treatment: specific issues related to safety, fertility, and pregnancy","volume":"40","author":"Hensley","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0240","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2141.2007.06542.x","article-title":"Successful pregnancies involving men with chronic myeloid leukaemia on Imatinib therapy","volume":"137","author":"Ramasamy","year":"2007","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.bulcan.2026.04.002_bib0245","doi-asserted-by":"crossref","first-page":"e0243045","DOI":"10.1371\/journal.pone.0243045","article-title":"Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a systematic review","volume":"15","author":"Szak\u00e1cs","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0250","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/ejh.13167","article-title":"Successful pregnancies in patients with BCR-ABL-positive leukemias treated with interferon-alpha therapy during the tyrosine kinase inhibitors era","volume":"101","author":"Balsat","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0255","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41375-024-02183-0","article-title":"Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87\u00a0patients reported to the European LeukemiaNet international registry","volume":"38","author":"Chelysheva","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0260","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/bjh.19491","article-title":"Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy","volume":"205","author":"Robertson","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0265","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.2015.62.4445","article-title":"Hematologic malignancies in pregnancy: management guidelines from an International Consensus Meeting","volume":"34","author":"Lishner","year":"2016","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.bulcan.2026.04.002_bib0270","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1182\/blood-2018-99-115984","article-title":"Kinetics of the leukemic clone in patients with chronic myeloid leukemia during pregnancy","volume":"132","author":"Chelysheva","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0275","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1080\/10428194.2018.1551533","article-title":"The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia","volume":"60","author":"Lasica","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0280","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10815-021-02181-6","article-title":"Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review","volume":"38","author":"Rambhatla","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0285","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1038\/s41375-023-02028-2","article-title":"Survival with chronic myeloid leukaemia after failing milestones","volume":"37","author":"Lauseker","year":"2023","journal-title":"Leukemia"},{"issue":"Suppl. 1","key":"10.1016\/j.bulcan.2026.04.002_bib0290","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1182\/blood-2018-99-119615","article-title":"Kinetics of BCR-ABL after TKI interruption during pregnancy in CML: a multinational retrospective analysis","volume":"132","author":"Lee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0295","doi-asserted-by":"crossref","first-page":"e35611","DOI":"10.1002\/cncr.35611","article-title":"Outcomes of pregnancy in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors","volume":"131","author":"Kondo","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.jp.7211665","article-title":"Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk","volume":"27","author":"Russell","year":"2007","journal-title":"J Perinatol"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0305","doi-asserted-by":"crossref","first-page":"e2018027","DOI":"10.4084\/mjhid.2018.027","article-title":"Breastfeeding in patients with chronic myeloid leukaemia: case series with measurements of drug concentrations in maternal milk and literature review","volume":"10","author":"Chelysheva","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.bulcan.2026.04.002_bib0310","series-title":"Drugs and Lactation Database (LactMed\u00ae) [Internet]","year":"2006"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126002845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126002845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:22:12Z","timestamp":1785928932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126002845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S0007455126002845"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.04.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vie sexuelle et reproductive des hommes et femmes atteints de leuc\u00e9mie my\u00e9lo\u00efde chronique\u00a0: opinion et propositions pratiques du groupe Fi-LMC","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}